Emerging Candida strain posing risk to in-patients in European healthcare facilities

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

The European Centre for Disease Prevention and Control (ECDC) is warning that there is a need to raise awareness in European healthcare facilities about Candida auris, in the interest of patient safety.

C. auris is a newly emerging yeast that was first described in 2009 and has subsequently been associated with invasive infections and outbreaks in healthcare settings worldwide, including hospitals in the UK and Spain.

In a Rapid Risk Assessment, the ECDC warned that C. auris can cause invasive infections in severely compromised patients. It said most isolates are resistant to fluconazole. Resistance to other antifungal agents has been reported, and multidrug-resistant C. auris isolates with resistance to all three main classes of antifungals, have been des...